AMRX 241220 15.00C (AMRX241220C15000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

AMRX241220C15000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 27 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Sector Update: Health Care Stocks Advance Premarket Friday
MT NewswiresNov 22 09:13 ET
Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved
WSJNov 21 17:05 ET
Express News | Amneal Pharmaceuticals Inc - FDA Review of Dhe Autoinjector Nda Expected by Q2 2025
ReutersNov 21 16:05 ET
Express News | Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
ReutersNov 21 16:05 ET
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
BusinesswireNov 21 16:05 ET
Truist Financial Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating
Moomoo NewsNov 21 07:34 ET · Ratings

Comments

Jaguar8

Nov 21 23:08

On watchlist. Reason: Resubmits Autoinjector NDA & Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist. News after hours

$Amneal Pharmaceuticals (AMRX.US)$

Trytosaveabit

Nov 21 15:08

News

$Amneal Pharmaceuticals (AMRX.US)$ Reuters· 2 mins ago
Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist

Trytosaveabit

Oct 21 07:01

News

$Amneal Pharmaceuticals (AMRX.US)$ Reuters· just
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets

Trytosaveabit

Oct 1 05:06

Update

$Amneal Pharmaceuticals (AMRX.US)$ Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
5 MINUTES AGO, 6:00 AM EDT
VIA BUSINESSWIRE
Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera's portfolio of novel injectable and oral development programs, including GLP-1 and amylin receptor agonists
Agreement provides Amneal w...

Trytosaveabit

Sep 5 15:07

Ne2s hehehe NEWS

$Amneal Pharmaceuticals (AMRX.US)$ Reuters
Amneal and Shilpa Announce U.S. FDA Approval of Boruzu™, the First Ready-to-Use Version of Bortezomib for Subcutaneous Administration